Upgrade to SI Premium - Free Trial

After-Hours Movers 03/21: (AMRN) Higher; (CNAT) (ZUO) (CAL) (more...)

March 21, 2019 5:09 PM
Today's After-Hours Movers:Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) 56% LOWER; announced top-line results from the companys Phase 2b ENCORE-NF clinical trial ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Special Reports

Next Articles